Chemical formula: C₂₀H₃₁NO₄ Molecular mass: 349.471 g/mol PubChem compound: 9930049
Vernakalant is an antiarrhythmic medicine that acts preferentially in the atria to prolong atrial refractoriness and to rate-dependently slow impulse conduction.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C01BG11 | Vernakalant | C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BG Other class I antiarrhythmics |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| BRIVANESS Concentrate for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC |
Vernakalant is an active ingredient of these brands:
Austria (AT)Canada (CA)Croatia (HR)Cyprus (CY)Estonia (EE)Finland (FI)Hong Kong (HK)Ireland (IE)Israel (IL)Lithuania (LT)Netherlands (NL)Poland (PL)Romania (RO)South Africa (ZA)Spain (ES)United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
